Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fierce Health vs MadeMed

Fierce Health
Graded #410

Lower grade

vs+23.800000000000004
MadeMed
Graded #30

Higher grade

The verdict

MadeMed takes it — 80.4/100 to 56.6/100.

MadeMed grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Publishes its price at every single dose, so what a titrated dose costs is knowable on day one.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMadeMed +41
33
74
Dose & formulationMadeMed +13
77
90
Clinical oversightMadeMed +22
62
84
Labs & monitoringMadeMed +10
52
62
FulfillmentMadeMed +15
75
90
Contract termsMadeMed +41
47
88
Fierce Health · left barMadeMed · right bar

The numbers

MetricFierce HealthMadeMed
WeighScore56.6/10080.4/100
GradeCB−
Scorecard rank#410#30
Semaglutide$297/mo (3-month plan, compounded)$239/mo quarterly (from $199/mo on 6 months)
Tirzepatide$497/mo (3-month plan, compounded)$399/mo quarterly (from $369/mo on 6 months)
Coverage30 states40 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
Fierce Health

Graded #410 · C

Strengths

  • 30-state service list spelled out in the Terms — buyers can verify eligibility before intake
  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer on every product page
  • Four GLP-1 programs (standard and microdose semaglutide and tirzepatide) — a broader ladder than peers
  • Microdose tier at $197/mo is one of the lower entry points we've seen

Where it loses points

  • No named 503A compounding pharmacy partner — only generic 'partner pharmacies' language
  • Operating LLC name not disclosed anywhere on the site
  • Tirzepatide weight-loss program ($497/mo) showing 'sold out or unavailable' across all plans at review time
  • Clinical provider network not named
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
MadeMed

Graded #30 · B−

Strengths

  • One flat price at every dose, published dose by dose — semaglutide 0.25–2.4mg, tirzepatide 2.5–15mg
  • LegitScript verified, with board-certified physician review and US compounding pharmacies
  • Full refund minus a $39 visit fee if you are not prescribed, stated before checkout
  • Oral semaglutide and oral tirzepatide alongside the injections; free overnight shipping with supplies

Where it loses points

  • The most expensive tirzepatide here at $399/mo quarterly
  • 40 states rather than nationwide
  • No published recurring lab programme
  • Ships one vial every two months, a less flexible cadence than a monthly refill

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard